Retrospective analysis of children diagnosed with Kawasaki disease
暂无分享,去创建一个
H. Çam | Murat Tuğberk Bakar | F. Varol | R. Dedeoglu | A. Kılıç | Sezgin Şahin | Özgür Kasapçopur | Amra Adrovic | Kenan Barut | Mehmet Yıldız
[1] M. Segelmark,et al. High risk of coronary artery aneurysm in Kawasaki disease , 2020, Rheumatology.
[2] Colin G Fink,et al. Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood , 2020, Frontiers in Pediatrics.
[3] Haobo Weng,et al. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm , 2020, Pediatric Research.
[4] Jie Tian,et al. Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis , 2019, Front. Pediatr..
[5] K. Gauvreau,et al. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population , 2019, Journal of the American Heart Association.
[6] L. Jung,et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition , 2019, Pediatric Rheumatology.
[7] T. Tsuchihashi,et al. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. , 2018, The Lancet. Child & adolescent health.
[8] L. B. Gámez-González,et al. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease , 2018, Pediatrics international : official journal of the Japan Pediatric Society.
[9] J. Ashworth,et al. Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..
[10] Yosikazu Nakamura,et al. Kawasaki disease: epidemiology and the lessons from it , 2017, International journal of rheumatic diseases.
[11] T. Kuijpers,et al. Giant aneurysms: A gender-specific complication of Kawasaki disease? , 2017, Journal of cardiology.
[12] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[13] O. Kasapcopur,et al. Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up , 2017, Cardiology in the Young.
[14] Fangqi Gong,et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease , 2017, Pediatric Rheumatology.
[15] M. Song,et al. Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease , 2016, Korean journal of pediatrics.
[16] O. Kasapcopur,et al. Pediatric vasculitis , 2016, Current opinion in rheumatology.
[17] A. Petrova,et al. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease. , 2014, Pediatrics and neonatology.
[18] R. Uehara,et al. Late Intravenous Immunoglobulin Treatment in Patients With Kawasaki Disease , 2012, Pediatrics.
[19] J. Burns,et al. Evolution of Laboratory Values in Patients With Kawasaki Disease , 2011, The Pediatric infectious disease journal.
[20] Victor Mor-Avi,et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[21] Victor Mor-Avi,et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[22] B. McCrindle,et al. Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. , 2009, The American journal of cardiology.
[23] Andrew M Kahn,et al. When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. , 2009, Journal of the American College of Cardiology.
[24] JungHwa Lee,et al. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor , 2009, European Journal of Pediatrics.
[25] R. Uehara,et al. Epidemiologic Features of Kawasaki Disease in Japan: Results from the Nationwide Survey in 2005-2006 , 2008, Journal of epidemiology.
[26] Xiao-hui Li,et al. Epidemiological survey of Kawasaki disease in Sichuan province of China. , 2007, Journal of tropical pediatrics.
[27] Tomio Kobayashi,et al. Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.
[28] P. Lysyansky,et al. Global longitudinal strain: a novel index of left ventricular systolic function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[29] H. Yanagawa,et al. Leukocyte counts in patients with Kawasaki disease: from the results of nationwide surveys of Kawasaki disease in Japan , 1997, Acta paediatrica.
[30] J. Newburger,et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. , 1986 .
[31] Katsuko Sato,et al. HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE , 1983, The Lancet.
[32] R. Alizadeh-Navaei,et al. Comparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications , 2016, Caspian journal of internal medicine.
[33] Nagib Dahdah,et al. New equations and a critical appraisal of coronary artery Z scores in healthy children. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[34] C. Rey,et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children , 2007, Intensive Care Medicine.
[35] P. Salamati,et al. RELATIONSHIP BETWEEN ESR, CRP, PLATELET COUNT AND CORONARY ARTERY DISEASE IN KAWASAKI DISEASE , 2005 .
[36] M. Mori,et al. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. , 2000, The Journal of pediatrics.
[37] R Gorlin,et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.